Navigation Links
Biodel Appoints Arthur Urciuoli to its Board of Directors
Date:9/17/2010

s, including, but not limited to, our ability to secure FDA approval for Linjeta(TM) and our other product candidates under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act; our ability to market, commercialize and achieve market acceptance for product candidates developed using our VIAdel(TM) technology, particularly Linjeta(TM) the progress or success of our research, development and clinical programs and the initiation and completion of our clinical trials; the FDA's findings regarding data anomalies observed in India in our Phase 3 clinical trial of Linjeta(TM) for patients with Type 1 diabetes; the possibility that patients taking Linjeta(TM) may experience more injection site discomfort than they experience with competing products; our ability to protect our intellectual property and operate our business without infringing upon the intellectual property rights of others; our estimates of future performance; our ability to enter into collaboration arrangements for the commercialization of our product candidates and the success or failure of those collaborations after consummation, if consummated; the rate and degree of market acceptance and clinical utility of our products; our commercialization, marketing and manufacturing capabilities and strategy; our estimates regarding anticipated operating losses, future revenues, capital requirements and our needs for additional financing; and other factors identified in our most recent quarterly report on Form 10-Q for the quarter ended June 30, 2010. The company disclaims any obligation to update any forward-looking statements as a result of events occurring after the date of this press release.Contact:The Trout Group LLCSeth D. Lewis, +1-646-378-2952
'/>"/>
SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
2. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
3. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
4. Biodel Announces Schedule for Presentations at the 37th Annual Meeting and Exposition of the Controlled Release Society
5. Biodel to Raise $9.4 Million Through Registered Direct Offering
6. Quark Pharmaceuticals Appoints New Chief Medical Officer
7. West Pharmaceutical Services, Inc. Appoints New Director
8. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
9. Curemark Appoints Preeminent Pediatrics Gastroenterologist
10. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
11. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... Quietly, sedately, Morocco,s pharmaceutical sector is shining. ... is strong, with a well-developed base of local producers ... One place where the quality of Moroccan pharma ... quietly become the second largest African exporter of drugs ... Moroccan pharma companies have been making inroads as exporters ...
(Date:7/31/2015)... CHICAGO , July 31, 2015 ... Composition Analyzers Market by Product (Bioimpedance Analyzers (BIA), Dual-Energy ... and Hydrostatic Weighing) - Global Analysis & Forecast to ... Market was pegged at $911.1 Million 2014 and is ... at a CAGR of 9.4% from 2014 to 2019. ...
(Date:7/30/2015)... IRIDEX Corporation (NASDAQ: IRIX ) today ... financial results after the market closes on Thursday, ... the Company will host a conference call with the ... Thursday, August 6, 2015 to discuss ... Interested parties may access the live conference ...
Breaking Medicine Technology:PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2
... ANTONIO, May 10, 2012 /PRNewswire-iReach/ -- ... a unique and innovative chronic wound treatment device, ... (Commerce City, CO) existing Federal Supply Schedule (FSS) ... (VA). The TransCu O2 ® , a noninvasive, ...
... LOUIS, May 9, 2012 Young Innovations, Inc. (NASDAQ ... declared a quarterly dividend of $0.04 per share, payable ... May 23, 2012. Young Innovations develops, manufactures ... hygienists, dental assistants and consumers. The Company,s consumables product ...
Cached Medicine Technology:New Chronic Wound Treatment Device Receives Award from Veterans Healthcare Program 2New Chronic Wound Treatment Device Receives Award from Veterans Healthcare Program 3Young Innovations, Inc. Board Of Directors Declares Quarterly Dividend 2
(Date:8/1/2015)... Bronx, NY (PRWEB) , ... August 01, 2015 , ... ... Torah scroll currently housed at their Bronx campus. The goal is to bring this ... once again be used in Jewish rituals and religious services. , Scroll No. ...
(Date:8/1/2015)... ... August 01, 2015 , ... Lume Wellness creators Alex, Robert, ... to download on the Apple AppStore. , The app is designed to track ... acting as a tool to view personal health and use this information for positive ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Ticket Down is a reputable source of authentic ... MGM Grand Garden Arena. Fans of every genre of music will have an act ... the first day of the festival, the following artists will perform: Sam Smith, Coldplay, ...
(Date:7/31/2015)... ... , ... Precision Aesthetics is New York’s only Thermage skin tightening pinnacle and ... of Exilis non-surgical fat reduction in New York. Due to its unparalleled level ... clientele. Many patients travel to New York to get their non-surgical skin tightening ...
(Date:7/31/2015)... , ... July 31, 2015 , ... There’s no better ... even when it comes time to cook the next meal, making July the most ... by practicing best grilling tips and recipes. , Make the next cookout different than ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3
... risk of spreading were 30% more likely to be ... treatment if their tumours were heated at the time ... bolsters the case for intensifying exploration of the strategy ... found that the addition of the innovative heat technique ...
... Breast Cancer Action Challenges Pharma Giant,s Marketing of the Artificial Hormone, ... SAN FRANCISCO, Sept. 22 Breast Cancer Action (BCA), known ... launch of their "Milking Cancer" campaign challenging the pharmaceutical giant Eli ... known as rBST) has long been linked to cancer. , ...
... ... left law firm Schroeter Goldmark & Bender after nearly twenty years to open her own ... ... has moved on after nearly 20 years at personal injury law firm Schroeter Goldmark & ...
... The answer to the ... best is unnecessary because there is a way to cut health care costs by 20%. , ... Los Angeles, CA (PRWEB) September 22, 2009 -- The answer ... plan is best is unnecessary because there is a way to cut health care costs ...
... , , NEW YORK, Sept. ... the first year of its four-year $12.5 million CGI Commitment ... resulted in dramatically improved quality and delivery of health services ... health managers to allocate resources in a way that rewards ...
... BRIDGEWATER, N.J., Sept. 16 Sanofi-aventis (EURONEXT: SAN and ... Food and Drug Administration (FDA) has issued a complete response ... (Ciltyri(R)). Eplivanserin was reviewed as a potential treatment for patients ... , Sanofi-aventis is currently reviewing the content ...
Cached Medicine News:Health News:Targeted heat therapy offers new standard treatment option for soft tissue sarcoma 2Health News:Targeted heat therapy offers new standard treatment option for soft tissue sarcoma 3Health News:Targeted heat therapy offers new standard treatment option for soft tissue sarcoma 4Health News:Cancer Advocacy Organization Confronts the Source of rBGH, Demands Pharmaceutical Giant Eli Lilly Stop 'Milking Cancer' 2Health News:Seattle Personal Injury Attorney Corrie Yackulic Opens Law Firm, Unveils New Website 2Health News:Powerful Key to Cutting Healthcare Costs Revealed in "The Self Image Solution" 2Health News:Clinton Global Initiative: September 22-25, 2009: Health Care Access and Quality Improves For Millions in Rwanda and Haiti Due to Innovative Performance-Based Financing Incentives 2Health News:Clinton Global Initiative: September 22-25, 2009: Health Care Access and Quality Improves For Millions in Rwanda and Haiti Due to Innovative Performance-Based Financing Incentives 3Health News:Sanofi-Aventis Receives Complete Response Letter from the FDA for Eplivanserin (Ciltyri(R)) Submission 2
... This latest sensor array ... average inter-channel spacing of just ... array is particularly useful when ... as Synthetic Aperture Magnetometry (SAM) ...
... Our unique Model Practice Eye can be used ... binocular indirect ophthalmoscopy, non-contact fundus biomicroscopy. ... a synthetic rubber which closely resembles the human ... texture of the sclera. The lens and ...
... Bi-Ostetic is a cost-effective synthetic ... Based on Tricalcium Phosphate (TCP) and ... of human bone. BAB formulates the ... enhance bone regeneration. This formulation provides ...
... pacing wire design offers reliable ... in the atrium and ventricle ... in one lead design. The ... ventricle are color-coded for easy ...
Medicine Products: